文献速递类风湿关节炎

中链甘油三酯补充改善类风湿关节炎患者生活质量维度:随机临床试验更新结果

Improvements in quality-of-life dimensions through medium-chain triglyceride (MCT) supplementation in rheumatoid arthritis: updated findings from a randomised clinical trial.
PubMed 文献 · RMD Open · 2026-02-16

一项随机双盲安慰剂对照试验纳入61例药物稳定治疗的类风湿关节炎患者,评估中链甘油三酯(MCT)及联合膳食纤维对健康相关生活质量、晨僵和疼痛的影响。结果显示,与对照组相比,MCT补充16周后患者在精神与躯体健康评分、晨僵强度与持续时间及疼痛强度方面均出现统计学和临床显著改善,加用纤维未干扰MCT疗效。

要点

  • MCT补充16周可显著改善RA患者精神健康、情绪健康、社会行为和活力等生活质量维度。
  • MCT显著降低晨僵强度和持续时间及疼痛强度,加用纤维后效果维持。
  • MCT可作为RA药物治疗之外靶向非药物干预的补充选择。

核心结论

  • 与对照组相比,RA患者补充MCT在多个健康相关生活质量组分上获得显著改善,加用纤维未干扰MCT疗效。

研究设计与样本

  • 随机、双盲、安慰剂对照临床试验纳入61例药物稳定治疗的RA患者。
  • 试验组每日两次补充MCT(30 g/天)8周,随后8周MCT(30 g/天)联合纤维(30 g/天);对照组以长链甘油三酯替代MCT。
  • 在基线(T0)、第8周(T2)和第16周(T4)评估生活质量参数、晨僵、疼痛强度和血脂谱。

主要发现

  • 16周后试验组在精神和躯体健康相关评分上均出现统计学和临床显著改善。
  • MCT显著改善精神健康、情绪健康、社会行为和活力(采用36项简表调查评估),从基线至T4及相对对照组均显著。
  • 采用多维疲劳量表-20评估,报告动机增加。
  • 与对照组相比,规律摄入MCT从基线至T4显著降低晨僵强度和持续时间及疼痛强度(视觉模拟量表评估)。
  • 加用纤维后报告的效果维持;基线血脂谱无显著差异。

关键数值与推荐

  • 试验组MCT补充剂量为30 g/天,分两次每日服用,持续8周,随后8周MCT(30 g/天)联合纤维(30 g/天)。
  • 对照组接受与试验组相同的补充方案,但以长链甘油三酯替代MCT。
  • 评估时间点为基线(T0)、第8周(T2)和第16周(T4)。

临床怎么用

  • 对于药物稳定治疗的RA患者,可考虑将MCT补充作为整合于药物治疗的靶向非药物方法,以改善生活质量和晨僵、疼痛症状。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the impact of medium-chain triglycerides (MCTs) and fibre on health-related quality of life (QOL), morning stiffness and pain in rheumatoid arthritis (RA) patients. METHODS: A randomised, double-blind, placebo-controlled clinical trial enrolled 61 RA patients on stable drug treatment. Participants received twice-daily MCT supplementation (30 g/day) for 8 weeks, followed by 8 weeks of MCTs (30 g/day) combined with fibre (30 g/day). The control group received the same supplementation as the test group, with long-chain triglycerides instead of MCTs. QOL parameters, morning stiffness, pain intensity and lipid profile were assessed at baseline (T0), week 8 (T2) and week 16 (T4). RESULTS: After 16 weeks, the test group showed statistically and clinically significant improvements both in mental and physical health-related scores. MCT consumption significantly ameliorated mental health, emotional well-being, social behaviour and vitality (measured using 36-Item Short Form Survey) from baseline to T4 and relative to control. An increased motivation, as assessed with the Multidimensional Fatigue Inventory-20 questionnaire, was reported as well. Regular intake of MCTs significantly reduced the intensity and duration of morning stiffness and pain intensity (assessed using the Visual Analogue Scale) from baseline to T4 compared with control group. Reported effects were maintained after adding fibre to supplementation. Baseline blood lipid profile showed no significant differences. CONCLUSIONS: Patients with RA supplemented with MCTs obtained significant improvements in several health-related QOL components compared to control, and fibre inclusion did not interfere with MCT efficacy. These results underscore the importance of targeted non-pharmacological approaches integrated to drug therapy in managing patients with RA. TRIAL REGISTRATION NUMBER: DRKS00025413.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Gaudioso G, Zanon P, Ciani S, et al. Improvements in quality-of-life dimensions through medium-chain triglyceride (MCT) supplementation in rheumatoid arthritis: updated findings from a randomised clinical trial. RMD Open. 2026. PMID: 41698796. doi:10.1136/rmdopen-2025-006036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。